| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 186,364 | 193,195 | 205,368 | 264,926 | | Cost of Revenue | 52,712 | 54,603 | 63,062 | 113,250 | | | Gross Profit | 133,652 | 138,592 | 142,306 | 151,676 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 102,855 | 123,601 | 167,201 | 87,068 | | Non Recurring | 642 | 218,433 | 1,493 | 60,977 | | Others | 10,866 | (205,965) | 228,514 | 12,214 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,062 | 2,523 | (254,902) | (8,583) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 43 | (230) | (1,028) | (24,639) | | Earnings Before Interest And Taxes | 19,918 | 2,924 | (256,349) | (19,427) | | Interest Expense | 1,149 | 163 | 246 | (58) | | Income Before Tax | 18,769 | 2,761 | (256,595) | (19,369) | | Income Tax Expense | 6,354 | 508 | (35,748) | (7,784) | | Minority Interest |
-
| 147 |
-
| 111 | | | | Net Income From Continuing Ops | 12,268 | 2,400 | (220,847) | (11,474) | | | Non-recurring Events | | Discontinued Operations | (15,676) |
-
|
-
| (1,144) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,261) | 2,400 | (220,847) | (12,618) | | Preferred Stock And Other Adjustments |
-
| (147) | 147 |
-
| | | Net Income Applicable To Common Shares | ($3,261) | $2,253 | ($220,700) | ($12,618) |
|
0.31% Nasdaq 
0.05%
Income Statement
